This guide gives you the complete, honest comparison mechanism, clinical trial data, side effect profiles, dosing schedules, and the practical considerations that determine which medication is the right starting point for you
But the story is more nuanced
COL12574FA072026 SPL8975O PRINCIPAL DISPLAY PANEL - 5 mg/500 mg Tablet Bottle Label NDC 0597-0159-60 DISPENSE WITH ACCOMPANYING MEDICATION GUIDE Synjardy (empagliflozin and metformin hydrochloride tablets) 5 mg/500 mg* Rx only 60 tablets Boehringer Ingelheim PRINCIPAL DISPLAY PANEL - 5 mg/1,000 mg Tablet Bottle Label NDC 0597-0175-60 DISPENSE WITH ACCOMPANYING MEDICATION GUIDE Synjardy (empagliflozin and metformin hydrochloride tablets) 5 mg/1,000 mg* Rx only 60 tablets Boehringer Ingelheim Frequently asked questions More about Synjardy (empagliflozin / metformin) Check interactions Compare alternatives Pricing & coupons Reviews (28) Drug images Side effects Dosage information During pregnancy Generic availability FDA approval history Drug class: antidiabetic combinations En espaol Patient resources Professional resources Other brands Related treatment guides Copyright 2026 Boehringer Ingelheim International GmbH ALL RIGHTS RESERVED

The stimulant-like mechanism creates dependency risks absent from GLP-1 agonists
Schedule your appointment today and experience the Bijoux difference, where luxury meets personalization, and your beauty journey truly begins.